Is Prism Medico overvalued or undervalued?

Sep 07 2025 08:01 AM IST
share
Share Via
As of September 5, 2025, Prism Medico is considered undervalued with a valuation grade of very attractive, supported by a PE ratio of 10.54, a Price to Book Value of 0.70, and an EV to EBITDA of 10.47, significantly lower than its peers like Apollo Hospitals and Max Healthcare, despite a 34.54% decline over the past year, while outperforming the Sensex with a 79.73% return over three years.
As of 5 September 2025, Prism Medico's valuation grade has moved from fair to very attractive, indicating a significant improvement in its market position. The company is currently considered undervalued. Key ratios supporting this assessment include a PE ratio of 10.54, a Price to Book Value of 0.70, and an EV to EBITDA of 10.47.

In comparison to its peers, Prism Medico stands out with a much lower PE ratio than Apollo Hospitals, which has a PE of 71.31, and Max Healthcare, which is at 94.34. This stark contrast highlights Prism Medico's relative undervaluation within the Non-Banking Financial Company sector. Additionally, while the stock has experienced a decline of 34.54% over the past year, it has outperformed the Sensex over a three-year period, with a return of 79.73% compared to the Sensex's 36.23%.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News